This brand name is authorized in Australia, Brazil, Spain, Japan, Netherlands, New Zealand, South Africa
The drug LEUSTATIN contains one active pharmaceutical ingredient (API):
1
Cladribine
UNII 47M74X9YT5 - CLADRIBINE
|
Cladribine is a nucleoside analogue of deoxyadenosine. In resting cells cladribine causes DNA single-strand breaks, rapid nicotinamide adenine dinucleotide consumption, ATP depletion and cell death. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
L01BB04 | Cladribine | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BB Purine analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 4326Q, 7225G |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 514501902157315 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61380 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4291408A1021 |
Country: NL | Z-Index G-Standaard | Identifier(s): 13927280 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 41785 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 7163 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 29/26/0404 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.